PURE Bioscience (PURE) Upgraded at ValuEngine

PURE Bioscience (OTCMKTS:PURE) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday.

Shares of PURE Bioscience (PURE) traded down 2.22% during trading on Tuesday, hitting $1.32. The stock had a trading volume of 70,744 shares. PURE Bioscience has a one year low of $0.75 and a one year high of $1.36. The stock’s market cap is $82.77 million. The stock’s 50-day moving average price is $1.06 and its 200 day moving average price is $0.95.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings results on Thursday, June 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.02). PURE Bioscience had a negative net margin of 276.96% and a negative return on equity of 125.22%. The firm had revenue of $0.34 million during the quarter, compared to analyst estimates of $1 million. On average, equities analysts forecast that PURE Bioscience will post ($0.10) EPS for the current year.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/2656295/pure-bioscience-pure-upgraded-at-valuengine.html.

PURE Bioscience Company Profile

PURE Bioscience, Inc is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC).new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “OTC:PURE”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.